News
Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...
Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback